Literature review highlights advances in photosensitizers and delivery for improved clinical outcomes in diverse fields.
Conclusions: Continued innovation in photosensitizer chemistry, nanotechnology-based delivery, and combination strategies promises to enhance PDT's selectivity, depth, and clinical effectiveness across oncology, dermatology, and infectious disease treatment.
No takes yet. Share an insight, caveat, or question.
Lipka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: